Paul J Gaglio

Summary

Affiliation: Montefiore Medical Center
Country: USA

Publications

  1. doi request reprint Complications in patients with alcohol-associated liver disease who undergo liver transplantation
    Paul J Gaglio
    Rutgers University College of Arts and Sciences, New Brunswick, NJ 08901, USA
    Clin Liver Dis 16:865-75. 2012
  2. doi request reprint Treatment of chronic hepatitis C in a slow responder: a case for extended therapy
    Paul J Gaglio
    Montefiore Einstein Liver Center, Greene Medical Arts Pavilion, Bronx, NY 10467, USA
    Nat Rev Gastroenterol Hepatol 6:372-5. 2009
  3. pmc Direct-acting antiviral therapy for hepatitis C: attitudes regarding future use
    Paul J Gaglio
    Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
    Dig Dis Sci 56:1509-15. 2011
  4. ncbi request reprint Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus
    Jordan M Schecter
    Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA
    Liver Transpl 13:1589-92. 2007
  5. ncbi request reprint Expedited liver allocation in the United States: a critical analysis
    Milan Kinkhabwala
    Montefiore Einstein Center for Transplantation, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
    Liver Transpl 19:1159-65. 2013
  6. doi request reprint Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
    Paul Feuerstadt
    Division of Gastroenterology, Department of Medicine, Montefiore Medical Center, The Albert Einstein College of Medicine, Bronx, NY, USA
    Hepatology 51:1137-43. 2010
  7. ncbi request reprint Hepatitis C-HIV coinfection: current and future therapy
    Jagdeep J Vyas
    Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, NY, NY 10032, USA
    Expert Rev Anti Infect Ther 1:433-9. 2003
  8. ncbi request reprint Scope of worldwide hepatitis C problem
    Robert S Brown
    Department of Medicine, Columbia University College of Physicians and Surgeons, and Center for Liver Disease and Transplantation, New York Presbyterian Hospital, New York, NY 10032, USA
    Liver Transpl 9:S10-3. 2003
  9. doi request reprint Social barriers to listing for adult liver transplantation: their prevalence and association with program characteristics
    Anna Flattau
    Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10467, USA
    Liver Transpl 17:1167-75. 2011
  10. ncbi request reprint Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy
    Paul J Gaglio
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Clin Infect Dis 45:618-23. 2007

Collaborators

Detail Information

Publications11

  1. doi request reprint Complications in patients with alcohol-associated liver disease who undergo liver transplantation
    Paul J Gaglio
    Rutgers University College of Arts and Sciences, New Brunswick, NJ 08901, USA
    Clin Liver Dis 16:865-75. 2012
    ..This article reviews important posttransplantation problems in patients transplanted for alcohol-associated liver disease...
  2. doi request reprint Treatment of chronic hepatitis C in a slow responder: a case for extended therapy
    Paul J Gaglio
    Montefiore Einstein Liver Center, Greene Medical Arts Pavilion, Bronx, NY 10467, USA
    Nat Rev Gastroenterol Hepatol 6:372-5. 2009
    ..A 49-year-old white man presented to his primary-care clinic with fatigue and poor concentration. He had an enlarged liver with a minimally tender edge and was subsequently referred to our liver clinic...
  3. pmc Direct-acting antiviral therapy for hepatitis C: attitudes regarding future use
    Paul J Gaglio
    Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA
    Dig Dis Sci 56:1509-15. 2011
    ..We hypothesize that current perceptions regarding the complexity of DAA therapy will influence attitudes towards future use by practitioners who are currently treating HCV...
  4. ncbi request reprint Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus
    Jordan M Schecter
    Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY, USA
    Liver Transpl 13:1589-92. 2007
    ..We present the first reported case of anti-erythropoietin antibody-mediated pure red cell aplasia arising in the setting of hepatitis C virus therapy in a patient who underwent living donor liver transplantation...
  5. ncbi request reprint Expedited liver allocation in the United States: a critical analysis
    Milan Kinkhabwala
    Montefiore Einstein Center for Transplantation, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
    Liver Transpl 19:1159-65. 2013
    ..Short-term graft function after EP allocation is excellent. Policies governing EP allocation should be created in order to improve access to available organs...
  6. doi request reprint Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients
    Paul Feuerstadt
    Division of Gastroenterology, Department of Medicine, Montefiore Medical Center, The Albert Einstein College of Medicine, Bronx, NY, USA
    Hepatology 51:1137-43. 2010
    ..Treatment with pegylated interferon and ribavirin was less effective in this population than is implied by multinational phase III controlled trials. New strategies are needed to care for such patients...
  7. ncbi request reprint Hepatitis C-HIV coinfection: current and future therapy
    Jagdeep J Vyas
    Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, NY, NY 10032, USA
    Expert Rev Anti Infect Ther 1:433-9. 2003
    ..In this review, the pathobiology, inter-relation of hepatitis C and HIV infection in coinfected patients as well as present and future treatment in this unique patient population are discussed...
  8. ncbi request reprint Scope of worldwide hepatitis C problem
    Robert S Brown
    Department of Medicine, Columbia University College of Physicians and Surgeons, and Center for Liver Disease and Transplantation, New York Presbyterian Hospital, New York, NY 10032, USA
    Liver Transpl 9:S10-3. 2003
    ..5. Despite a declining incidence of new infections, the burden of disease, both in terms of mortality and in terms of cost, is expected to increase over the next decade...
  9. doi request reprint Social barriers to listing for adult liver transplantation: their prevalence and association with program characteristics
    Anna Flattau
    Department of Family and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10467, USA
    Liver Transpl 17:1167-75. 2011
    ....
  10. ncbi request reprint Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy
    Paul J Gaglio
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Clin Infect Dis 45:618-23. 2007
    ..The management of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) coinfection is challenged by the selection of patients for therapy, options for antiviral medications, and inconsistency in published treatment guidelines...
  11. ncbi request reprint Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors
    Paul J Gaglio
    Department of Medicine, Columbia University College of Physicians and Surgeons, Center for Liver Disease and Transplantation, New York Presbyterian Hospital, New York, NY 10032, USA
    Liver Transpl 9:1028-35. 2003
    ..Thus, in this patient population, the timing and incidence of HCV recurrence were not different when comparing CAD versus LDLT, but the incidence of cholestatic hepatitis was significantly greater in patients with HCV who underwent LDLT...